Pharma Journalist - Page 804 of 957 -

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

MyBiotics signs second option agreement with Ferring Holding for the validation

Benitec Biopharma initiates Phase 2 Oncology Study in Australia

Trovagene confirms enrollment of First patient for Cycle 1 Treatment with PCM-075

Lyric finishes enrollment in Phase 2 PRROMOTE Study of LP101 in Enteral Feeding Intolerance

Glenmark Pharmaceuticals presents New Data on Ryaltris for treating SAR at AAAAI/WAO

The future of parenteral drug delivery

Aimmune Therapeutics declares results of Phase 3 PALISADE Trial of AR101 for peanut allergy patients

MeiraGTx declares EMA’s extension of PRIME designation to A002